-
UnitedHealth Group posts $5.5B profit in Q2
UnitedHealth Group recorded double-digit growth in revenue year over year across its lines of business at UnitedHealthcare and Optum, according to the company's second-quarter earnings report released July 14. -
Medicare Advantage's growth spurt won't last forever: McKinsey
Medicare Advantage enrollment has grown rapidly in recent years, now enrolling over half of Medicare eligibles. But payers shouldn't expect the growth to last forever, analysts for McKinsey and Company say. -
How Health Care Service Corp. made prior authorization 1,400 times faster with AI
Health Care Service Corporation, which operates Blue Cross Blue Shield affiliates in Illinois, Texas, Oklahoma, Montana and New Mexico, is expanding AI technology to speed up prior authorization. -
Ozempic demand is driving up care costs nationwide
Health insurers around the country are looking to raise premiums next year in part to meet the high demand for expensive weight-loss drugs such as Ozempic. -
25 payers on Threads, Meta's new Twitter competitor
The vast majority of health insurers have a presence across social media sites, and some have made the jump to the newest platform, Threads, a Twitter competitor from Facebook's parent company, Meta Platforms. -
7 recent research findings from payers
Payers use claims data, member demographics and more to uncover new findings. -
10 ways payers can respond to the changing Medicare Advantage market, per McKinsey
Payers should start evolving their strategies to be digital first, and streamline administration to respond to headwinds in the Medicare Advantage market, analysts for McKinsey and Company said in a July 11 report. -
Excellus BCBS received $5.4M in Medicare Advantage overpayments, OIG says
Excellus BlueCross BlueShield received an estimated $5.4 million in Medicare Advantage overpayments in 2017 and 2018, according to an audit from HHS' Office of Inspector General. -
'We expected it to be bad': Harvard professor on Medicaid redeterminations
The Medicaid redetermination process is off to a poor start, according to Adrianna McIntyre, PhD, an assistant professor of health policy and politics at Boston-based Harvard T.H. Chan School of Public Health. -
The 10 drugs Medicare spends the most on
Five of the 10 drugs with the highest Medicare Part D spending are diabetes treatments, including Ozempic, according to an analysis from KFF. -
Johns Hopkins HealthCare rebranding as Johns Hopkins Health Plans
Johns Hopkins HealthCare, the insurance arm of Baltimore-based Johns Hopkins Medicine, is rebranding as Johns Hopkins Health Plans. -
Cigna in the headlines: 7 recent updates
The Cigna Group named a new leader for its Medicare business and settled several legal actions in recent weeks. -
6 payers entering new markets
From specialty Medicare Advantage plans to continued investment in care delivery services, these are six payers entering new markets, as reported by Becker's since April 1: -
Minnesota fines Medica, enacts 2-year supervision period for violating mental health parity laws
The Minnesota Department of Commerce has fined Medica $300,000 and imposed a two-year monitoring period for what it says are violations of mental health parity laws. -
Payer price transparency data has been available for a year. Is it lowering costs?
Price transparency data is available, but several changes are needed to actually bring about lower healthcare costs, researchers at Washington, D.C.-based Georgetown University's Center for Health Insurance Reforms wrote. -
Why Blue Cross Blue Shield companies are reorganizing
Two nonprofit Blue Cross Blue Shield companies will reorganize this year, hoping to stay competitive with for-profit rivals like UnitedHealth Group and Aetna. -
17 payers among best companies to work for disability inclusion in 2023
17 payers have been recognized for their initiatives around disability inclusion and equality for their employees in the 2023 Disability Equality Index, a national benchmarking survey created by Disability:IN and the American Association of People with Disabilities. -
North Carolina indefinitely delays specialty Medicaid plans
The North Carolina Department of Health and Human Services is again delaying the implementation of its Medicaid managed care behavioral health and intellectual/developmental disabilities tailored plans, this time to an undetermined date. -
Lawmakers questioning Medicare on Leqembi costs, coverage
Medicare will cover Alzheimer's disease treatment Leqembi, but lawmakers have questions on the agency's approach and the drug's high cost. -
Gold Kidney Health Plan entering Florida Medicare Advantage market
Gold Kidney Health Plan, a Medicare Advantage insurer offering chronic special needs plans, is expanding to Florida in 2024.
Page 45 of 50